MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
Volume 0.58M
Average 0.84M
MGTX Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
MeiraGTx Holdings plcNASDAQ: MGTX
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $3.21M rose 132.7% year over year, ahead of the -73.5% change in trailing-twelve-month cost of revenue. Sequentially, it rose 573.5% from the prior quarter.
Context
- Cost of revenue amounted to 6.0% of revenue in FY2025, down 65.5 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +132.7% holds above the trailing-twelve-month pace of -73.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 4.84M USD
- Year-over-year change
- -79.6%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.84M | -79.6% |
| FY2024 | 2024-12-31 | 23.79M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Cost of Revenue vs competitors
How MGTX compares with its peers on the latest reported figures
- MGTX's LTM Mar 2026 cost of revenue of $6.67M is the 5th highest of the 9 companies compared; the peer median is $17.01M.
- Its year-over-year change of -73.5% is the lowest of 7, against a peer median of -1.2%.
- Cost of revenue amounts to 8.4% of revenue for MGTX, versus a peer median of 25.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $167.7M | -26.7% | +28.1% | 253.7% | |
| LTM Mar 2026 | $99.22M | -12.1% | -54.4% | 112.4% | |
| LTM Mar 2026 | $87.94M | +139.2% | -28.1% | 100.1% | |
| LTM Jun 2026 | $29.34M | +23.1% | — | 6.7% | |
| LTM Mar 2026 | $6.67M | -73.5% | — | 8.4% | |
| LTM Mar 2026 | $4.68M | -49.7% | -20.4% | 25.9% | |
| LTM Mar 2026 | $2.39M | — | — | — | |
| LTM Mar 2026 | $298K | +9.6% | +5.1% | 2.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MGTX) | $17.01M | -1.2% | -20.4% | 25.9% | |
Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 37.7M | 15.92M | 14.02M | 33.28M | 81.39M |
| Cost of Revenue | 0 | 0 | 0 | 23.79M | 4.84M |
| Gross Profit | 37.7M | 15.92M | 14.02M | 9.49M | 76.55M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 28.5% | 94.0% |
| Research & Development | 66.69M | 85.73M | 103.79M | 119.48M | 129.62M |
| Selling, General & Admin | 43.77M | 46.55M | 47.29M | 54.22M | 52.9M |
| Operating Expenses | 110.46M | 132.28M | 151.08M | 173.7M | 182.52M |
| Depreciation & Amortization | 7.87M | 8.6M | 13.73M | 12.83M | 12.61M |
| EBITDA | (71.4M) | (116.07M) | (57.05M) | (121.69M) | (89.4M) |
| EBITDA Margin | -189.4% | -729.1% | -407.0% | -365.7% | -109.8% |
| Operating Income | (72.76M) | (116.36M) | (137.06M) | (164.21M) | (105.97M) |
| Operating Margin | -193.0% | -730.9% | -977.8% | -493.4% | -130.2% |
| Interest Income | 212K | 777K | 2.27M | 4.15M | 1.82M |
| Interest Expense | 288K | 4.95M | 13.25M | 13.27M | 12.2M |
| Other Income / Expenses | (6.8M) | (13.26M) | 53.03M | 16.42M | (8.23M) |
| Income Before Tax | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Pre-Tax Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Net Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| EPS (Basic) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| EPS (Diluted) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| Weighted Avg Shares | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
| Weighted Avg Shares (Diluted) | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
MeiraGTx Holdings plc
NASDAQ:MGTX
Intrinsic Alpha fair value
Locked
Current Price
$8.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.